Omega-3 Index: 20 years of research
The concept of the Omega-3 Index was first introduced by Dr. William S. Harris and Dr. Clemens von Schacky in their groundbreaking 2004 paper. This index measures the percentage of EPA and DHA, essential omega-3 fatty acids, in the red blood cell membranes. Their pioneering research established the Omega-3 Index as a significant predictor of heart disease risk, proposing that higher levels of these fatty acids in blood cells were associated with a reduced risk of heart-related deaths.
Today, the Omega-3 Index has evolved beyond its initial cardiovascular focus and is recognised for its broader implications in overall health. The index is widely used in clinical settings and research.
Leading the Way in Omega-3 Science and Global Testing
50,000 Scientific Publications
Omega-3 fatty acids are backed by an extensive body of research, with over 50,000 scientific publications exploring their health benefits.
5,000 Human Clinical Trials
Omega-3 fatty acids have been the subject of over 5,000 human clinical trials, highlighting their significant health benefits.
1,000,000 Test Performed
Omega-3 testing has been widely adopted, with over 1,000,000 test performed to date.
Laboratories
We have established a global presence with labs in the UK, Europe, Australia and the USA, allowing us to serve customers worldwide.